Artificial intelligence is dominating headlines, telehealth has settled into a new normal, and digital health continues to promise transformation. However, much of what is being discussed in healthcare today reflects potential rather than reality.
The gap between what is possible and what is actually happening in clinical practice remains wide. This article focuses on separating signal from noise and highlights the trends clinicians should pay attention to now.
Key Takeaways
- AI is advancing quickly, but real clinical adoption and validation remain limited.
- Mental health demand continues to outpace how primary care is structured to deliver it
- Patient digital readiness is still being overlooked, despite its impact on outcomes.
- Remote patient monitoring is entering a phase of scrutiny after years of expansion
- Cost pressures remain one of the most consistent drivers of patient behavior.
AI in Healthcare: What Is Actually Changing Clinical Practice?
Why AI Adoption in Healthcare Still Lags Behind the Hype
Research from Anthropic suggests that AI could perform a large share of tasks across multiple industries. In practice, however, adoption remains far below that level.
This gap is often framed as an untapped opportunity. It is more accurately understood as a reflection of how difficult it is to integrate AI into real clinical workflows. Healthcare is not a controlled environment, and tools that perform well in theory often struggle in practice.
Vendor-driven narratives tend to emphasize future potential. The more relevant question for clinicians is whether these tools improve care today.
Most Healthcare AI Tools Lack Real-World Clinical Validation
A meta-analysis in Nature Medicine found that fewer than 1% of studies on large language models were conducted in live clinical settings. Most evidence still comes from simulated or synthetic settings.
This is a critical limitation. Healthcare does not operate in controlled conditions, and results from simulated environments often overstate real-world performance.
There is a growing volume of research on AI, but relatively little of it answers the question that matters most: Does it improve patient care in practice?
How AI Improves Efficiency but Can Weaken Clinical Judgment
Research in Computers in Human Behavior shows that AI can improve performance when used alongside humans. At the same time, it increases overconfidence.
AI tools tend to reinforce existing assumptions rather than challenge them. This creates a risk that clinicians may feel more confident without being more accurate.
Implication for clinicians: AI is most useful when it is treated as something to challenge, not something to trust by default. The risk is not that AI replaces clinicians, but that it subtly alters decision-making in ways that are harder to detect.
Mental Health Demand Is Reshaping Primary Care Delivery
Data from Medscape shows that more than half of primary care clinicians frequently encounter patients with mental health needs.
This is no longer a secondary issue. Mental health has effectively become a core component of primary care, yet most systems are not structured to support it.
Clinicians face predictable constraints:
- Limited time.
- Limited training.
- Unclear reimbursement pathways.
These are not new problems, but they are becoming more consequential as demand increases.
Implication for clinicians: The current model of referring out or addressing mental health within a limited visit time is increasingly insufficient. Structural changes, not incremental adjustments, will likely be required.
Patients Are Using AI for Health Information and Symptom Support
Data from Microsoft and the Kaiser Family Foundation shows that patients are already integrating AI into their health management.
This is not a future trend. It is already happening, often outside the visibility of clinicians.
Patients use these tools for symptom checking, education, and emotional support, particularly during hours when access to care is limited. Accuracy is not always the primary concern. Immediacy is.
Implication for clinicians: The question is no longer whether patients will use these tools. The question is whether clinicians acknowledge and incorporate that reality into care delivery.
Why Patient Digital Readiness Matters in Digital Health Adoption
Despite ongoing investment in digital health, many organizations still do not assess whether patients can effectively use these tools. Research from UCSF highlights that digital readiness is often assumed rather than measured.
This assumption creates a disconnect. Healthcare systems continue to deploy digital solutions, while some patients cannot meaningfully engage with them.
Implication for clinicians: Digital access is not the same as digital readiness. Without addressing this gap, additional technology may widen disparities rather than reduce them.
Telehealth Utilization Trends: From Pandemic Surge to Long-Term Normalization
Data from FAIR Health shows that telehealth has reached a steady baseline after its pandemic-driven surge.
This stabilization is often interpreted as a plateau. It is more accurately viewed as a normalization phase, where telehealth is finding its appropriate role within care delivery.
Mental health remains the dominant use case, reinforcing where virtual care provides the most value.
Telehealth Adoption Remains Lower in Rural Communities
Research in JAMA Network Open shows that telehealth adoption is significantly lower in rural areas, despite being positioned as a solution for access challenges.
This suggests that access issues are more complex than availability alone. Infrastructure, literacy, and trust all play a role.
Implication for clinicians: Expanding telehealth access requires more than offering virtual visits. It requires addressing the underlying barriers that prevent adoption.
Remote Patient Monitoring Faces Growing Pressure to Prove Value
Remote patient monitoring expanded rapidly, supported by favorable reimbursement and strong expectations. That phase is ending.
Analysis from Trilliant Health indicates that payers are increasingly questioning its value.
This shift was predictable. Technologies that scale quickly without consistent outcome data eventually face scrutiny.
Implication for clinicians: The focus is shifting from adoption to justification. Programs that demonstrate clear clinical value will persist, while others may not.
Healthcare Costs Continue to Influence Patient Care Decisions
Data from the Kaiser Family Foundation Health System Tracker shows that cost remains a consistent barrier to care.
Patients are delaying or avoiding care, and many are concerned about their ability to pay. Price transparency efforts have improved visibility but have not meaningfully changed behavior or outcomes.
This reflects a broader issue. Information alone does not change decisions when underlying costs remain high.
Implication for clinicians: Cost is not a secondary concern for patients. It is often a primary factor influencing whether care is pursued at all.
Healthcare Technology Is Entering an Era of Accountability
Healthcare is moving out of a phase defined by rapid innovation and into one defined by accountability. The focus is shifting from what technology can do to what it actually delivers.
AI, telehealth, and digital tools will continue to evolve. The differentiator will not be access to technology, but the ability to implement it in ways that improve real outcomes.
Clinicians and healthcare organizations that focus on practical integration, patient readiness, and measurable value will be better positioned to navigate this shift.
Disclosures:
- The author serves as Head of Strategy at Doxy.me, the telehealth technology company that owns telehealth.org.
- The views expressed in this commentary are those of the author and do not necessarily reflect the views of Telehealth.org.
- AI tools may have assisted in drafting or editing; the author or editorial team reviewed and approved all content.
- This article is not legal or medical advice.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]















